Pitch Deck & Market Context

Unlocking the 80% of Healthcare Data Trapped in Text

MiimansaAI is designed for an already-proven, fast-growing clinical NLP market — occupying a specific, high-margin wedge in protocol authoring and pharmacovigilance workflow automation.

Market Sizing & Growth Drivers

A $2.4B–$3B Category at ~24% CAGR

Analyst forecasts for the broader healthcare NLP market range from $11B to over $100B by 2035 — signaling an actively forming market rather than a commoditized one.

$2.4B–$3B

Clinical NLP Market Today

Projected to reach $7B–$13B by 2030–2034 at a ~24% CAGR, driven by EHR adoption, clinical documentation burden, and medical coding demands.

80%

Unstructured Clinical Data

Roughly 80% of healthcare data (physician notes, discharge summaries, trial narratives) is unstructured and completely unusable by downstream systems without extraction.

65%+

Compliance Barrier

Over 65% of healthcare IT leaders name compliance and data privacy as their #1 adoption barrier. Average healthcare breach cost exceeds $10M per incident.

Category Validation

Proven Technology & M&A Lineage

This category is not a hypothetical experiment. Major cloud NLP platforms and specialized medical NLP vendors have validated enterprise demand for entity extraction and SNOMED/ICD-10 normalization.

Notably, Miimansa AI — the company referenced in original clinical entity modeling benchmarks — built protocol authoring and medical writing automation tools that were acquired into Emmes Group's "Concord" Gen AI platform in 2024.

Strategic Takeaway: You don't need to prove clinical NLP works — the category is proven. Your pitch is about owning a specific underserved workflow (CRO protocol authoring & AE coding) with a fast SaaS deployment model.

Strategic Positioning: The Wedge

Don't Sell "General Clinical NLP for Everyone"

Competing directly with giant cloud providers on raw infrastructure scale is not winnable as a new SaaS.

Do Sell "Clinical Protocol & AE Coding Workflow Automation"

Target mid-market CROs and biotech medical writers who lack custom NLP engineering teams and need transparent per-document pricing.

Product & Engineering Roadmap

From Pitch Concept to Production Engine

Being explicit about current frontend prototype vs full backend roadmap.

CURRENT BUILD
Phase 0 — High-Fidelity Concept & Workflow Showcase

Interactive annotation engine demo, full marketing site, product architecture guide, pricing calculator, and HITL validation UI preview.

ROADMAP NEXT
Phase 1 — Wrapped NER Model & Normalization Engine

Wrap specialized clinical NLP engines (or custom fine-tuned transformer models) with MiimansaAI's proprietary trait layer, SNOMED concept linker, and FHIR serializer.

ROADMAP STAGE 2
Phase 2 — Auth, Encrypted Document Store & Audit Logging

Multi-tenant organization auth, end-to-end encrypted document storage, and Part 11 compliant audit logging.

ROADMAP STAGE 3
Phase 3 — BAA Execution & SOC 2 / HIPAA Certification

Formal BAA contracts for enterprise CRO customers, SOC 2 Type II auditing, and HIPAA compliance verification.